Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,309 | 35,029 | 56,984 | 30,522 | 32,722 |
| Marketable Securities | 137,358 | 114,992 | 101,981 | 115,916 | 120,425 |
| Receivables | 28,651 | 25,901 | 25,855 | 25,919 | 24,281 |
| Inventories | 60,916 | 63,744 | 61,645 | 56,132 | 48,769 |
| TOTAL | $257,989 | $248,625 | $252,582 | $233,100 | $229,626 |
| Non-Current Assets | |||||
| PPE Net | 99,282 | 95,846 | 90,324 | 86,323 | 77,809 |
| Investments And Advances | 0 | 13,470 | 13,462 | 17,921 | 17,941 |
| Intangibles | 42,751 | 32,784 | 30,961 | 29,049 | 27,365 |
| Other Non-Current Assets | 677 | 481 | 406 | 2,595 | 2,252 |
| TOTAL | $142,710 | $142,581 | $135,153 | $135,888 | $125,367 |
| Total Assets | $400,699 | $391,206 | $387,735 | $368,988 | $354,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,614 | 10,484 | 8,739 | 8,471 | 13,299 |
| Accrued Expenses | 38,330 | 29,067 | 35,375 | 30,295 | 26,790 |
| TOTAL | $150,438 | $146,139 | $149,788 | $145,411 | $145,472 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,048 | 1,275 | 1,426 | 1,426 | 1,426 |
| Other Non-Current Liabilities | 14,163 | 11,020 | 11,473 | 6,125 | 5,447 |
| TOTAL | $21,910 | $18,897 | $19,555 | $14,564 | $14,242 |
| Total Liabilities | $172,348 | $165,036 | $169,343 | $159,975 | $159,714 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,278 | 37,167 | 37,053 | 36,757 | 36,647 |
| Common Shares | 37 | 37 | 37 | 37 | 37 |
| Retained earnings | -320,101 | -312,143 | -308,289 | -305,791 | -308,877 |
| Other shareholders' equity | 138 | 49 | -52 | -29 | -27 |
| TOTAL | $228,351 | $226,170 | $218,392 | $209,013 | $195,279 |
| Total Liabilities And Equity | $400,699 | $391,206 | $387,735 | $368,988 | $354,993 |